Advanced search
Publication Cover
Journal of Drug Assessment Volume 7, 2018 - Issue 1
Journal homepage
1,709
Views
20
CrossRef citations to date
0
Altmetric
Oncology

Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)

Utkarsh H. AcharyaClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (WA), USA; ;Division of Medical Oncology, University of Washington, Seattle (WA), USA; Correspondence[email protected]
,
Anna B. HalpernClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (WA), USA; ;Division of Medical Oncology, University of Washington, Seattle (WA), USA;
,
Qian (Vicky) WuClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (WA), USA;
,
Jenna M. VoutsinasClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (WA), USA;
,
Roland B. WalterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (WA), USA; ;Division of Medical Oncology, University of Washington, Seattle (WA), USA;
,
Seongseok YunDivision of Medical Oncology, Moffitt Cancer Center, Tampa (FL) USA;
,
Mohammed KanaanDivision of Hematology-Oncology, University of Arizona Cancer Center, Tucson(AZ), USA;
&
Elihu H. EsteyDivision of Hematology, University of Washington, Seattle (WA), USA
 show all
Pages 51-53 | Received 05 Mar 2018, Accepted 13 Jun 2018, Published online: 10 Jul 2018

References

  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–1152.
  • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. JCO. 2003;21:4642–4649.
  • Hossain MJ, Xie L. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: evidence from us population data. Cancer Epidemiol. 2015;39:892–900.
  • Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481–3485.
  • Leith CP, Kopecky KJ, Godwin J, et al. Acute Myeloid Leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest oncology group study. Blood. 1997;89:3323–3329.
  • Bhatt VR, Shostrom V, Giri S, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017;92:764–771.
  • Ailawadhi S, Advani P, Yang D, et al. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis. Cancer. 2016;122:618–625.
  • Ghaffary C, Dafashy T, Kosarek CD, et al. Impact of proximity to NCI- and NCCN- designated cancer centers on outcomes for patients with prostate cancer undergoing radical prostatectomy. Journal of Clinical Oncology. 2017;35:14–14.
  • Muffly L, Alvarez E, Lichtensztajn D, et al. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study. Blood Adv. 2018;2:895–903.
  • Giri S, Pathak R, Aryal MR, et al. Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study. Blood. 2015;21125:3359–3360.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.